PFU
ELV icon

Parus Finance (UK)’s Elevance Health ELV Stock Holding History

Parus Finance (UK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Sell
10,148
-523
-5% -$194K 1.02% 18
2026
Q1 		$3.12M Sell
10,671
-568
-5% -$187K 0.93% 20
2025
Q4 		$3.94M Buy
11,239
+150
+1% +$50.7K 1.04% 19
2025
Q3 		$3.58M Sell
11,089
-170
-2% -$52.9K 0.94% 18
2025
Q2 		$4.38M Sell
11,259
-788
-7% -$317K 1.25% 16
2025
Q1 		$5.24M Sell
12,047
-359
-3% -$144K 1.79% 15
2024
Q4 		$4.58M Buy
12,406
+30
+0.2% +$12.6K 1.43% 19
2024
Q3 		$6.44M Sell
12,376
-3,860
-24% -$2.06M 2.07% 15
2024
Q2 		$8.8M Buy
16,236
+602
+4% +$318K 2.54% 14
2024
Q1 		$8.11M Sell
15,634
-1,221
-7% -$607K 3.05% 12
2023
Q4 		$7.95M Buy
16,855
+417
+3% +$193K 4.13% 10
2023
Q3 		$7.16M Sell
16,438
-1,635
-9% -$742K 4.46% 10
2023
Q2 		$8.03M Sell
18,073
-722
-4% -$333K 3.32% 9
2023
Q1 		$8.64M Buy
18,795
+450
+2% +$214K 5.17% 5
2022
Q4 		$9.41M Sell
18,345
-490
-3% -$249K 6.39% 6
2022
Q3 		$8.56M Buy
18,835
+665
+4% +$318K 7.43% 5
2022
Q2 		$8.77M Buy
18,170
+296
+2% +$146K 5.21% 8
2022
Q1 		$8.78M Sell
17,874
-5,793
-24% -$2.65M 3.14% 11
2021
Q4 		$11M Sell
23,667
-1,868
-7% -$786K 3.52% 8
2021
Q3 		$9.52M Sell
25,535
-3,880
-13% -$1.47M 2.74% 14
2021
Q2 		$11.2M Buy
29,415
+164
+0.6% +$62.7K 2.72% 14
2021
Q1 		$10.5M Buy
29,251
+1,361
+5% +$438K 2.88% 11
2020
Q4 		$8.96M Sell
27,890
-2,290
-8% -$703K 2.62% 16
2020
Q3 		$8.11M Sell
30,180
-750
-2% -$202K 2.76% 14
2020
Q2 		$8.13M Buy
30,930
+6,870
+29% +$1.83M 3.52% 12
2020
Q1 		$5.46M Sell
24,060
-18,000
-43% -$4.91M 6.08% 8
2019
Q4 		$12.7M Buy
42,060
+12,050
+40% +$3.32M 6.43% 6
2019
Q3 		$7.21M Buy
+30,010
New +$8.22M 4.54% 8

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parus Finance (UK)'s ELV Position: Q2 2026 in Review

Parus Finance (UK) reduced its Elevance Health (ELV) stake by 4.9% in Q2 2026, selling an estimated $194K and leaving 10,148 shares worth $3.92M. The position accounts for 1.02% of the portfolio, ranked #18.

Parus Finance (UK) first reported a position in ELV in Q3 2019 and has held it in 28 quarters since. The position peaked at $12.7M in Q4 2019. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Parus Finance (UK) held 10,148 shares of Elevance Health worth $3.92M as of Q2 2026.
  • Parus Finance (UK) sold 523 Elevance Health shares in Q2 2026, an estimated $194K.
  • Elevance Health made up 1.02% of Parus Finance (UK)'s portfolio in Q2 2026, its #18 holding.
  • Parus Finance (UK) first reported a position in Elevance Health in Q3 2019 and has held it in 28 quarters since.
  • Parus Finance (UK)'s Elevance Health position peaked at $12.7M in Q4 2019.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Parus Finance (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.